Form 8.3 - Aon Plc

By

Regulatory News | 03 Jul, 2020

Updated : 15:21

RNS Number : 0290S
BlackRock Group
03 July 2020
 

Ap19

 

 

FORM 8.3

 

IRISH TAKEOVER PANEL

 

DISCLOSURE UNDER RULE 8.3 OF THE IRISH TAKEOVER PANEL ACT, 1997, TAKEOVER RULES, 2013

 

DEALINGS BY PERSONS WITH INTERESTS IN RELEVANT SECURITIES REPRESENTING 1% OR MORE

 

1.       KEY INFORMATION

 

Name of person dealing (Note 1)

BlackRock, Inc.

Company dealt in

Aon plc

Class of relevant security to which the dealings being disclosed relate (Note

US$0.01 ordinary shares

Date of dealing

02 July 2020

 

2.         INTERESTS AND SHORT POSITIONS

 

(a)        Interests and short positions (following dealing) in the class of relevant security dealt in (Note 3)

 

Long

Short

 

Number

 

(%)

Number

 

(%)

(1) Relevant securities

16,680,675 (7.20%)

12,591 (0.00%)

(2) Derivatives (other than options)

30,801 (0.01%)

186,251 (0.08%)

(3) Options and agreements to purchase/sell

0 (0.00%)

0 (0.00%)

Total

16,711,476 (7.21%)

198,842 (0.08%)

       

 

(b)        Interests and short positions in relevant securities of the company, other than the class dealt in (Note 3)

Class of relevant security:

Long

Short

 

Number

 

(%)

Number

 

(%)

(1) Relevant securities

 

 

 

(2) Derivatives (other than options)

 

 

 

(3) Options and agreements to purchase/sell

 

 

Total

 

 

       

 

Ap20

 

 

1.       DEALINGS (Note 4)

 

(a)      Purchases and sales

 

 

 

Purchase/sale

 

Number of relevant securities

 

Price per unit (Note 5)

Purchase

2,014

USD 191.4500

Purchase

13

USD 191.4500

Purchase

115

USD 192.2024

Sale

1,872

USD 191.4500

Sale

898

USD 191.8614

Sale

7,771

USD 191.9080

Sale

822

USD 191.8976

   

Please note: there was also a Transfer In of 9,873 Shares

 

 

(b)      Derivatives transactions (other than options transactions)

 

Product name,

e.g. CFD

Nature of transaction

(Note 6)

Number of relevant securities

(Note 7)

Price per unit

(Note 5)

CFD

Reducing Short

234

USD 191.9047

CFD

Reducing Short

364

USD 191.9925

CFD

Reducing Short

161

USD 192.0175

CFD

Increasing Short

2,012

USD 191.8461

CFD

Increasing Short

33

USD 191.8645

   

(c)      Options transactions in respect of existing relevant securities

 

 

(i)       Writing, selling, purchasing or varying

 

Product name,

e.g. call option

Writing, selling, purchasing, varying etc.

Number of securities to which the option relates (Note 7)

Exercise price

Type, e.g. American, European etc.

Expiry date

Option money paid/received per unit (Note 5)

 

 

 

 

 

 

 

 

(ii)      Exercising

 

Product name,

e.g. call option

Number of securities

Exercise price per unit (Note

 

 

 

 

(d)      Other dealings (including transactions in respect of new securities) (Note 4)

 

Nature of transaction

(Note 8)

Details

Price per unit

(if applicable) (Note 5)

Stock on Loan

416,300

N/A

Return of Stock on Loan

181,500

N/A

   

 

Ap21

 

2.       OTHER INFORMATION

 

Agreements, arrangements or understandings relating to options or derivatives

 

 

Full details of any agreement, arrangement or understanding between the person disclosing and 

any other person relating to the voting rights of any relevant securities under any option referred to 

on this form or relating to the voting rights or future acquisition or disposal of any relevant securities to 

which any derivative referred to on this form is referenced. If none, this should be stated.

 

 

 

None

 

 

 

Is a Supplemental Form 8 attached? (Note 9)                                    NO

 

Date of disclosure

03 July 2020

Contact name

Jana Blumenstein

Telephone number

+44 20 7743 3650

If a connected EFM, name of offeree/offeror with which connected

 

If a connected EFM, state nature of connection (Note 10)

 

 

 


This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
 
END
 
 
ISESSDFDDESSEFW

Last news